Pooled analysis of the reports of erlotinib after failure of gefitinib for non-small cell lung cancer
K Kaira, T Naito, T Takahashi, E Ayabe, R Shimoyama… - Lung Cancer, 2010 - Elsevier
PURPOSE: The use of erlotinib after gefitinib failure in patients with non-small cell lung
cancer (NSCLC) is not clearly clarified in clinical practice. We sought to compile the …
cancer (NSCLC) is not clearly clarified in clinical practice. We sought to compile the …
[引用][C] Pooled analysis of the reports of erlotinib after failure of gefitinib for non-small cell lung cancer
K Kaira, T Naito, T Takahashi, E Ayabe, R Shimoyama… - Lung Cancer, 2010 - cir.nii.ac.jp
Pooled analysis of the reports of erlotinib after failure of gefitinib for non-small cell lung
cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データを …
cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データを …
Pooled analysis of the reports of erlotinib after failure of gefitinib for non-small cell lung cancer
K Kaira, T Naito, T Takahashi, E Ayabe… - Lung …, 2010 - lungcancerjournal.info
Purpose The use of erlotinib after gefitinib failure in patients with non-small cell lung cancer
(NSCLC) is not clearly clarified in clinical practice. We sought to compile the available …
(NSCLC) is not clearly clarified in clinical practice. We sought to compile the available …
Pooled analysis of the reports of erlotinib after failure of gefitinib for non-small cell lung cancer.
K Kaira, T Naito, T Takahashi, E Ayabe… - Lung Cancer …, 2009 - europepmc.org
Purpose The use of erlotinib after gefitinib failure in patients with non-small cell lung cancer
(NSCLC) is not clearly clarified in clinical practice. We sought to compile the available …
(NSCLC) is not clearly clarified in clinical practice. We sought to compile the available …
[PDF][PDF] Pooled analysis of the reports of erlotinib after failure of gefitinib for non-small cell lung cancer
K Kaira, T Naito, T Takahashi, E Ayabe… - Lung …, 2010 - researchgate.net
abstract Purpose: The use of erlotinib after gefitinib failure in patients with non-small cell
lung cancer (NSCLC) is not clearly clarified in clinical practice. We sought to compile the …
lung cancer (NSCLC) is not clearly clarified in clinical practice. We sought to compile the …
[引用][C] Pooled analysis of the reports of erlotinib after failure of gefitinib for non-small cell lung cancer
K KAIRA, T NAITO, A TSUYA, Y NAKAMURA… - Lung …, 2010 - pascal-francis.inist.fr
Pooled analysis of the reports of erlotinib after failure of gefitinib for non-small cell lung
cancer CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
cancer CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
Pooled analysis of the reports of erlotinib after failure of gefitinib for non-small cell lung cancer
K Kaira, T Naito, T Takahashi… - Lung cancer …, 2010 - pubmed.ncbi.nlm.nih.gov
Purpose The use of erlotinib after gefitinib failure in patients with non-small cell lung cancer
(NSCLC) is not clearly clarified in clinical practice. We sought to compile the available …
(NSCLC) is not clearly clarified in clinical practice. We sought to compile the available …
Pooled analysis of the reports of erlotinib after failure of gefitinib for non-small cell lung cancer
K Kaira, T Naito, T Takahashi, E Ayabe, R Shimoyama… - Lung Cancer, 2010 - infona.pl
The use of erlotinib after gefitinib failure in patients with non-small cell lung cancer (NSCLC)
is not clearly clarified in clinical practice. We sought to compile the available clinical reports …
is not clearly clarified in clinical practice. We sought to compile the available clinical reports …